+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Genfit - logo

GENFIT is a biopharmaceutical company that focuses on developing diagnostic solutions to address high unmet patient needs in metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. Its lead pipeline product elafibranor (GFT505) has recently completed a positive Phase 2b study in NASH (Non-Alcoholic Steato-Hepatitis). Genfit SA was founded in 1999 and is headquartered in Loos, France.

Primary biliary cirrhosis - Pipeline Insight, 2024 - Product Thumbnail Image

Primary biliary cirrhosis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 120 Pages
  • Global
From
Non-Alcoholic Steatohepatitis Treatment Global Market Report 2024 - Product Thumbnail Image

Non-Alcoholic Steatohepatitis Treatment Global Market Report 2024

  • Report
  • February 2024
  • 200 Pages
  • Global
From
Psoriasis - Pipeline Review, H2 2020 - Product Thumbnail Image

Psoriasis - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 956 Pages
  • Global
From
Fatty Liver Treatment Global Market Report 2024 - Product Thumbnail Image

Fatty Liver Treatment Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Non-Alcoholic Steatohepatitis (NASH) Global Market Report 2024 - Product Thumbnail Image

Non-Alcoholic Steatohepatitis (NASH) Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Alcoholic Hepatitis Treatment Global Market Report 2024 - Product Thumbnail Image

Alcoholic Hepatitis Treatment Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Liver Diseases Therapeutics Global Market Report 2024 - Product Thumbnail Image

Liver Diseases Therapeutics Global Market Report 2024

  • Report
  • February 2024
  • 200 Pages
  • Global
From
Non-Alcoholic Steatohepatitis (NASH) - Global Clinical Trials Review, 2022 - Product Thumbnail Image

Non-Alcoholic Steatohepatitis (NASH) - Global Clinical Trials Review, 2022

  • Clinical Trials
  • January 2022
  • 561 Pages
  • Global
From
Cirrhosis - Pipeline Insight, 2024 - Product Thumbnail Image

Cirrhosis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 200 Pages
  • Global
From
Primary Biliary Cholangitis - Pipeline Insight, 2024 - Product Thumbnail Image

Primary Biliary Cholangitis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Competitor Landscape: Non-alcoholic Steatohepatitis (NASH) - Product Thumbnail Image

Competitor Landscape: Non-alcoholic Steatohepatitis (NASH)

  • Report
  • November 2018
  • 52 Pages
  • Global
From
Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Report and Forecast 2023-2031 - Product Thumbnail Image

Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Report and Forecast 2023-2031

  • Report
  • March 2023
  • 147 Pages
  • Global
From
Primary Biliary Cholangitis - Market Insight, Epidemiology And Market Forecast - 2032 - Product Thumbnail Image

Primary Biliary Cholangitis - Market Insight, Epidemiology And Market Forecast - 2032

  • Report
  • February 2023
  • 195 Pages
  • Global
From
Liver Failure - Pipeline Insight, 2024 - Product Thumbnail Image

Liver Failure - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 70 Pages
  • Global
From
Non-Alcoholic Steatohepatitis (NASH) Disease - Global Clinical Trials Review, H1, 2021 - Product Thumbnail Image

Non-Alcoholic Steatohepatitis (NASH) Disease - Global Clinical Trials Review, H1, 2021

  • Clinical Trials
  • February 2021
  • 469 Pages
  • Global
From
NASH Drug Pipeline and Market Overview - Product Thumbnail Image

NASH Drug Pipeline and Market Overview

  • Report
  • January 2020
  • 18 Pages
  • Global
From
Opioid Antagonist Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application, Product Type - Product Thumbnail Image

Opioid Antagonist Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • January 2024
  • 100 Pages
  • Global
From
Global Non-Alcoholic Steatohepatitis Market: Analysis By Drug Type, By Application Type, By Distribution Type, By Region Size and Trends with Impact of COVID-19 and Forecast up to 2027 - Product Thumbnail Image

Global Non-Alcoholic Steatohepatitis Market: Analysis By Drug Type, By Application Type, By Distribution Type, By Region Size and Trends with Impact of COVID-19 and Forecast up to 2027

  • Report
  • January 2023
  • 130 Pages
  • Global
From
Mitochondrial Disease Therapies Market, 2019-2030 - Product Thumbnail Image

Mitochondrial Disease Therapies Market, 2019-2030

  • Report
  • July 2019
  • 250 Pages
  • Global
From
Non-alcoholic steatohepatitis (NASH) Market and Forecast Analysis to 2038 - Product Thumbnail Image

Non-alcoholic steatohepatitis (NASH) Market and Forecast Analysis to 2038

  • Report
  • January 2021
  • 102 Pages
  • Global
Loading Indicator